Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors

Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions

(2014) Ingvild Løberg Tangen et al.   EUROPEAN JOURNAL OF CANCER

Expression Profiling of Primary and Metastatic Ovarian Tumors Reveals Differences Indicative of Aggressive Disease

(2014) Alexander S. Brodsky et al.   PLoS One

Progesterone Receptor Signaling in the Microenvironment of Endometrial Cancer Influences Its Response to Hormonal Therapy

(2013) D. M. Janzen et al.   CANCER RESEARCH

Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial

(2013) Jone Trovik et al.   EUROPEAN JOURNAL OF CANCER

Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma

(2013) Jutta Huvila et al.   GYNECOLOGIC ONCOLOGY

Evolution of intratumoral phenotypic heterogeneity: the role of trait inheritance

(2013) J. Gallaher et al.   Interface Focus

Clinicopathologic Analysis of Matched Primary and Recurrent Endometrial Carcinoma

(2012) Robert A. Soslow et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis

(2012) M. V. Dieci et al.   ANNALS OF ONCOLOGY

Cellular Heterogeneity and Molecular Evolution in Cancer

(2012) Vanessa Almendro et al.   Annual Review of Pathology-Mechanisms of Disease

Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia

(2012) Maria Santacana et al.   HISTOPATHOLOGY

The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer

(2012) Gian Franco Zannoni et al.   HUMAN PATHOLOGY

Markers for individualised therapy in endometrial carcinoma

(2012) Helga B Salvesen et al.   LANCET ONCOLOGY

Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies

(2011) Eitan Amir et al.   CANCER TREATMENT REVIEWS

Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas

(2010) Victoria Wargon et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer

(2008) Vincent Jongen et al.   GYNECOLOGIC ONCOLOGY

Epigenetics in Cancer

(2008) Manel Esteller   NEW ENGLAND JOURNAL OF MEDICINE

Changes and Predictive and Prognostic Value of the Mitotic Index, Ki-67, Cyclin D1, and Cyclo-oxygenase-2 in 710 Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

(2008) F. Penault-Llorca et al.   ONCOLOGIST

The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology

(2007) D.S. CHI et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER